A Phase 2b/3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of ABT-494 compared to placebo for induction and maintenance therapy in subjects with moderately to severely active ulcerative colitis 27 de Setembro, 2019 By admin